Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

NCT01393340 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01393340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
December 31, 2009
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, nasal polyposis